352 related articles for article (PubMed ID: 32050446)
1. The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2020 Feb; 25(3):. PubMed ID: 32050446
[TBL] [Abstract][Full Text] [Related]
2. The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
G de la Torre B; Albericio F
Molecules; 2019 Feb; 24(4):. PubMed ID: 30813407
[TBL] [Abstract][Full Text] [Related]
3. The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
Torre BG; Albericio F
Molecules; 2021 Jan; 26(3):. PubMed ID: 33504104
[TBL] [Abstract][Full Text] [Related]
4. The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495494
[TBL] [Abstract][Full Text] [Related]
5. The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164339
[TBL] [Abstract][Full Text] [Related]
6. The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770706
[TBL] [Abstract][Full Text] [Related]
7. The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338330
[TBL] [Abstract][Full Text] [Related]
8. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type.
Torre BG; Albericio F
Molecules; 2017 Feb; 22(3):. PubMed ID: 28264468
[TBL] [Abstract][Full Text] [Related]
9. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
10. Lessons from 60 years of pharmaceutical innovation.
Munos B
Nat Rev Drug Discov; 2009 Dec; 8(12):959-68. PubMed ID: 19949401
[TBL] [Abstract][Full Text] [Related]
11. Recent drug approvals from the US FDA and EMEA: what the future holds.
Pevarello P
Future Med Chem; 2009 Apr; 1(1):35-48. PubMed ID: 21426069
[TBL] [Abstract][Full Text] [Related]
12. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
13. 2018 in review: FDA approvals of new molecular entities.
Kinch MS; Griesenauer RH
Drug Discov Today; 2019 Sep; 24(9):1710-1714. PubMed ID: 31158510
[TBL] [Abstract][Full Text] [Related]
14. 2021 FDA TIDES (Peptides and Oligonucleotides) Harvest.
Al Shaer D; Al Musaimi O; Albericio F; de la Torre BG
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215334
[TBL] [Abstract][Full Text] [Related]
15. The year's new drugs & biologics 2016: Part I.
Graul AI; Pina P; Cruces E; Stringer M
Drugs Today (Barc); 2017 Jan; 53(1):27-74. PubMed ID: 28387385
[TBL] [Abstract][Full Text] [Related]
16. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
17. Data Integrity: History, Issues, and Remediation of Issues.
Rattan AK
PDA J Pharm Sci Technol; 2018; 72(2):105-116. PubMed ID: 29158286
[TBL] [Abstract][Full Text] [Related]
18. New FDA breakthrough-drug category--implications for patients.
Darrow JJ; Avorn J; Kesselheim AS
N Engl J Med; 2014 Mar; 370(13):1252-8. PubMed ID: 24670173
[No Abstract] [Full Text] [Related]
19. Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases.
DiMasi JA; Florez MI; Stergiopoulos S; Peña Y; Smith Z; Wilkinson M; Getz KA
Clin Pharmacol Ther; 2020 Feb; 107(2):324-332. PubMed ID: 31502248
[TBL] [Abstract][Full Text] [Related]
20. The FDA Breakthrough-Drug Designation - Four Years of Experience.
Darrow JJ; Avorn J; Kesselheim AS
N Engl J Med; 2018 Apr; 378(15):1444-1453. PubMed ID: 29641970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
